BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3469285)

  • 1. [Studies on the use of CA-125 in gynecologic mass screening].
    Nakatani K; Hoshiai H; Wada Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):157-60. PubMed ID: 3469285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum CA-125 level in patients with gynecologic tumors].
    Abe Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Saito J; Nishino T
    Rinsho Byori; 1984 Dec; 32(12):1350-4. PubMed ID: 6597876
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening for malignant gynecologic tumors].
    Ebeling K
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):715-9. PubMed ID: 8237067
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for gynecologic cancer.
    Campion MJ; Reid R
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):695-727. PubMed ID: 2092238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for gynecologic cancer].
    Yajima A; Sato S; Masuda K; Nagai H; Mori T
    Gan No Rinsho; 1990 Aug; 36(10):1128-32. PubMed ID: 2214149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer screening for women older than 40 years of age.
    Runowicz CD; Goldberg GL; Smith HO
    Obstet Gynecol Clin North Am; 1993 Jun; 20(2):391-408. PubMed ID: 8367140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organization of prophylactic gynecologic exams with mass cytological screening of women].
    Buval'tseva NA; Kvashenko BK
    Pediatr Akus Ginekol; 1978; (3):35-6. PubMed ID: 673514
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimum screening interventions for gynecologic malignancies.
    Lea JS; Miller DS
    Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA-125 and endometriosis.
    Barbieri RL
    Contrib Gynecol Obstet; 1987; 16():103-8. PubMed ID: 2446822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 72.4, SCC, 90 K].
    Garzetti GC; Di Lauro RM; Ciavattini A; Pallotta MR; Marchegiani F; Valensise H; Tranquilli AL; Arduini D; Romanini C
    Ann Ostet Ginecol Med Perinat; 1991; 112(5):320-3. PubMed ID: 1817444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
    Jacobs IJ; Oram DH; Bast RC
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of registration of gynecologic malignant neoplasms in Shizuoka Prefecture--evaluation for one and a half years].
    Hayata T; Sumimoto K; Terao T; Kawashima Y; Nagano T
    Gan No Rinsho; 1985 Feb; 31(2):179-84. PubMed ID: 3989986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening in gynecologic oncology].
    Ebeling K
    Zentralbl Gynakol; 1983; 105(19):1225-38. PubMed ID: 6316692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 15. [On a mass screening survey for gynecologic carcinomata in a rural community].
    Montanari GR; Grismondi GL; Marconato A; Gioia E; Montanari GD
    Attual Ostet Ginecol; 1968; 14(5):413-5. PubMed ID: 5737605
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of monoclonal antibody to 19-9 antigen as a potential screening technique for colorectal cancer in a high-risk population.
    Verrill H; Goldberg M; Kovac G; Atkinson B; Herlyn M
    Prog Clin Biol Res; 1984; 156():107-14. PubMed ID: 6382320
    [No Abstract]   [Full Text] [Related]  

  • 17. [The function of the mass screening center of practicing gynecologists in Bern?].
    Kaufmann P
    Gynakol Rundsch; 1977; 17(2):102-5. PubMed ID: 560331
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for gynecologic malignancies: A continuing responsibility.
    Runowicz CD; Fields AL
    Surg Oncol Clin N Am; 1999 Oct; 8(4):703-23, vii. PubMed ID: 10452936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our responsibility in the field of gynecologic cancer].
    Dolhay B; Jakubecz S; Papp Z; Herpay G; Gardó S
    Orv Hetil; 1968 Dec; 109(5):2821-5. PubMed ID: 5717809
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.